跳至主要内容
临床试验/NCT01719913
NCT01719913已完成不适用

Gut, Grain and Greens (3G): The Effect of Gluten on Gut Microbiome and Metabolic Health.

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Altered quantitative metagenomics at bacterial gene- and species levels.

研究概览

简要总结

Objective: To identify how specific changes of the gluten content in the diet affect the host-gut microbiome interactions with implications for metabolic health.

Design: A randomized, controlled, single-blinded, cross-over intervention trial consisting of two 8-week interventions periods, separated by a 6-week wash-out period. A total number of 60 participants will be included.

Intervention: low vs high gluten intake.

详细描述

The study is designed as a randomized, controlled, single-blinded, cross-over intervention trial consisting of two 8-week interventions periods, separated by a 6-week wash-out period. A total number of 60 participants will be included. Participants consume, in randomized order, a gluten-poor diet (<5 g/d) in the active treatment period and a gluten-rich diet (>25 g/d) during the control period.

Measurements: Altered quantitative metagenomics at bacterial gene- and species levels is the primary outcome of this study. Secondary outcomes include metabolic and inflammatory markers, circulating appetite hormone levels,serum metabolomics, gastrointestinal transit time and intestinal permeability. Furthermore, selected control measures are included; 4-day food records and a study intervention dietary records.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Pharmacological treatment; diabetes and blood lipid regulation
  • Lactating (or lactating, 6 weeks ago), pregnant (or pregnant, 3 months ago) or wish to become pregnant during the study
  • Participation in another biomedical trial 1 month prior to study start
  • Diagnosed with any form of diabetes, celiac disease or chronic pancreatitis
  • Reported chronic gastrointestinal disorders
  • Antibiotic treatment for 3 month prior to study start
  • Blood hemoglobin < 7.0 mmol/l
  • Blood donation within 1 month prior to study start

结局指标

主要结局

Altered quantitative metagenomics at bacterial gene- and species levels.

时间窗: Up to 3 years.

Feces samples are collected according to standard operation procedures for subsequent standardized microbial DNA extraction. Microbial DNA will be subjected to sequencing, microbial gene analyses, taxonomy analyses including enterotypes known species and unknown meta-species and functional annotation.

次要结局

  • Colonic fermentation(Up to 2 years.)
  • Mean intestinal transit time(Up to 2 years.)
  • Gastrointestinal permeability.(Up to 2 years.)
  • Blood pressure and pulse.(Up to 1 year.)
  • Saliva microbial flora(Up to 2 years.)
  • Nasal fluid(Up to 3 years.)
  • Appetite hormones(Up to 3 years.)
  • Celiac disease markers(Up to 1 year.)
  • Blood lipid profile(Up to 2 years.)
  • Bioimpedance(Up to 1 year.)
  • Breath hydrogen.(Up to 2 years.)
  • Insulin(Up to 2 years.)
  • Glucose(Up to 2 years.)
  • C-peptide(Up to 2 years.)
  • Inflammatory makers(Up to 3 years.)
  • Anthropometric characteristics.(Up to 1 year.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oluf Borbye Pedersen

Scientific Director, professor

University of Copenhagen

研究点 (2)

Loading locations...

相似试验